Experimental diagnosis of patients with abnormal fibrinogen

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100050709

Enrollment

Unknown

Registered

2021-09-03

Start date

2021-09-01

Completion date

Unknown

Last updated

2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abnormal fibrinogen

Interventions

Gold Standard:Prothrombin time (PT), activated partial thromboplastin time (APTT),thrombin time (TT),fibrinogen (Fg).

Index test:Fibrinogen&#32

(Clauss&#32

and&#32

(PT-algorithm&#32

Eligibility

Sex/Gender

All

Age

1 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Obtain the informed consent of the subjects; 2. Patients with afibrinogenemia, hypofibrinogenemia, dysfibrinogenemia, hypofibrinogenemia and hyperfibrinogenemia.

Exclusion criteria

Exclusion criteria: 1. Patients with incomplete clinical data; 2. Patients who received blood transfusion within the previous 3 months were included.

Design outcomes

Primary

Measure	Time frame
Fibrinogen concentration (Clauss method);Fibrinogen concentration (PT-algorithm method);	—

Countries

China

Contacts

Public ContactLin Faquan

The First Affiliated Hospital of Guangxi Medical University

fqlin1998@163.com+86 13877118318

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026